Stakeholder Perspectives on Navigating Evidentiary and Decision Uncertainty in Precision Oncology
(1) Background: Precision oncology has the potential to improve patient health and wellbeing through targeted prevention and treatment. Owing to uncertain clinical and economic outcomes, reimbursement has been limited. The objective of this pan-Canadian qualitative study was to investigate barriers...
Main Authors: | Samantha Pollard, Jessica Dunne, Sarah Costa, Dean A. Regier |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/12/1/22 |
Similar Items
-
Editorial: Oral Oncology: From Precise Surgery to Precision Medicine and Surgery
by: Zuzana Saidak, et al.
Published: (2022-04-01) -
Heterogeneity in precision oncology
by: Bartłomiej Tomasik, et al.
Published: (2024-01-01) -
Integration of artificial intelligence and precision oncology in Latin America
by: Liliana Sussman, et al.
Published: (2022-10-01) -
Oncology providers’ perspectives on endocrine therapy prescribing and management
by: Wheeler SB, et al.
Published: (2016-09-01) -
The Future of Precision Oncology
by: Stuart L. Rulten, et al.
Published: (2023-08-01)